Alcon, a global leader in eye care, has officially opened its expanded manufacturing and logistics facility in Tuas Biomedical Park, Singapore, marking 20 years of operations in the country. The expansion, celebrated on 27 June, underscores Alcon’s commitment to innovation and precision manufacturing, with over $600m invested to date. The facility is set to create high-value jobs in production, quality control, and distribution, reinforcing Singapore’s role as a strategic hub for Alcon’s operations in Asia.
The state-of-the-art Tuas facility is equipped with advanced automation and smart manufacturing systems, designed to meet the growing global demand for Alcon’s contact lenses, including the flagship PRECISION1 lenses featuring SMARTSURFACE Technology. Patrick Collier, Senior Vice President of Global Manufacturing and Technical Operations at Alcon, stated, “The expanded Tuas facility will not only enhance our ability to serve patients’ ocular health needs globally but also advance our mission to help people see brilliantly.”
The expansion aligns with Singapore’s ambition to grow its MedTech workforce, which includes over 400 companies and employs more than 16,000 people. Alcon’s partnerships with local educational institutions and workforce development programmes aim to nurture capabilities in precision engineering and AI-driven automation.
The facility’s design focuses on sustainability, achieving zero waste to landfill and offering scalable production capabilities. Goh Wan Yee, Senior Vice President of Healthcare for the Singapore Economic Development Board, remarked on the milestone, highlighting Alcon’s role in enhancing advanced manufacturing capabilities and driving sustainable practices in Singapore’s MedTech sector.
“`
